{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:25:28Z","timestamp":1790807128115,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.bulcan.2018.08.003","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T04:26:38Z","timestamp":1538022398000},"page":"907-917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Recommandations fran\u00e7aises du Groupe G\u00e9n\u00e9tique et Cancer pour l\u2019analyse en panel de g\u00e8nes dans les pr\u00e9dispositions h\u00e9r\u00e9ditaires au cancer du sein ou de l\u2019ovaire"],"prefix":"10.1016","volume":"105","author":[{"given":"Jessica","family":"Moretta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascaline","family":"Berthet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Bonadona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Cohen-Haguenauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrystelle","family":"Colas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Corsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronica","family":"Cusin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3898-073X","authenticated-orcid":false,"given":"Antoine","family":"De Pauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Capucine","family":"Delnatte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Dussart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Jamain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Longy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Luporsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Maugard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tan Dat","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Vaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Andrieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lasset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Nogu\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5182","key":"10.1016\/j.bulcan.2018.08.003_bib0265","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"issue":"6559","key":"10.1016\/j.bulcan.2018.08.003_bib0270","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2","volume":"378","author":"Wooster","year":"1995","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.bulcan.2018.08.003_bib0275","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for brca1\u00a0and brca2\u00a0mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.bulcan.2018.08.003_bib0280","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1\u00a0and BRCA2\u00a0penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.bulcan.2018.08.003_bib0285","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa1400382","article-title":"Breast-cancer risk in families with mutations in PALB2","volume":"371","author":"Antoniou","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.bulcan.2018.08.003_bib0290","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10549-015-3625-7","article-title":"Mutation analysis of PALB2\u00a0gene in French breast cancer families","volume":"154","author":"The GENESIS Study Investigators","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.bulcan.2018.08.003_bib0295","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jamaoncol.2014.168","article-title":"Hereditary diffuse gastric cancer syndrome: CDH1\u00a0mutations and beyond","volume":"1","author":"Hansford","year":"2015","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2018.08.003_bib0300","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jso.23735","article-title":"Cowden syndrome: recognizing and managing a not-so-rare hereditary cancer syndrome: Cowden syndrome","volume":"111","author":"Mester","year":"2015","journal-title":"J Surg Oncol"},{"issue":"5","key":"10.1016\/j.bulcan.2018.08.003_bib0305","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nrclinonc.2014.41","article-title":"Li-Fraumeni syndrome: cancer risk assessment and clinical management","volume":"11","author":"McBride","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.bulcan.2018.08.003_bib0310","series-title":"Oncog\u00e9n\u00e9tique en 2016\/consultations, laboratoires et suivi, INCa\u00a9","author":"INCa.","year":"2017"},{"issue":"7","key":"10.1016\/j.bulcan.2018.08.003_bib0320","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1200\/JCO.2013.49.7271","article-title":"Cancer genomics and inherited risk","volume":"32","author":"Stadler","year":"2014","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.bulcan.2018.08.003_bib0325","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1200\/JCO.2015.65.0747","article-title":"Frequency of Germline mutations in 25\u00a0cancer susceptibility genes in a sequential series of patients with breast cancer","volume":"34","author":"Tung","year":"2016","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.bulcan.2018.08.003_bib0330","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","article-title":"Gene-panel sequencing and the prediction of breast-cancer risk","volume":"372","author":"Easton","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.bulcan.2018.08.003_bib0335","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/ejhg.2014.16","article-title":"Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes","volume":"22","author":"Cast\u00e9ra","year":"2014","journal-title":"Eur J Hum Genet"},{"issue":"8","key":"10.1016\/j.bulcan.2018.08.003_bib0340","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/gim.2014.176","article-title":"Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1\/2-negative patients with early-onset breast cancer","volume":"17","author":"Maxwell","year":"2015","journal-title":"Genet Med"},{"issue":"19","key":"10.1016\/j.bulcan.2018.08.003_bib0345","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1200\/JCO.2013.53.6607","article-title":"Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment","volume":"32","author":"Kurian","year":"2014","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2018.08.003_bib0350","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/jmedgenet-2015-103452","article-title":"Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families","volume":"53","author":"Li","year":"2016","journal-title":"J Med Genet"},{"issue":"9","key":"10.1016\/j.bulcan.2018.08.003_bib0355","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrclinonc.2016.90","article-title":"Counselling framework for moderate-penetrance cancer-susceptibility mutations","volume":"13","author":"Tung","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.bulcan.2018.08.003_bib0360","series-title":"Synth\u00e8se \u2013 Femmes porteuses d\u2019une mutation de BRCA1\u00a0ou BRCA2\/D\u00e9tection pr\u00e9coce du cancer du sein et des annexes et strat\u00e9gies de r\u00e9duction du risque","year":"2017"},{"key":"10.1016\/j.bulcan.2018.08.003_bib0365","series-title":"D\u00e9pistage du cancer du sein en France\u00a0: identification des femmes \u00e0 haut risque et modalit\u00e9s de d\u00e9pistage","author":"Recommandation Haute Autorit\u00e9 de sant\u00e9","year":"2014"},{"issue":"4","key":"10.1016\/j.bulcan.2018.08.003_bib0375","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.patbio.2006.02.002","article-title":"Identification and management of hereditary breast-ovarian cancers (2004\u00a0update)","volume":"54","author":"Eisinger","year":"2006","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.bulcan.2018.08.003_bib0380","series-title":"Institut national du cancer","year":"2017"},{"issue":"3","key":"10.1016\/j.bulcan.2018.08.003_bib0385","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10549-016-4003-9","article-title":"Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care","volume":"160","author":"Graffeo","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bulcan.2018.08.003_bib0390","series-title":"Fiches t\u00e9l\u00e9chargeables panel GGC sein\/ovaire","year":"2017"},{"issue":"23","key":"10.1016\/j.bulcan.2018.08.003_bib0395","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1002\/cncr.30248","article-title":"Risks of first and subsequent cancers among TP53\u00a0mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort","volume":"122","author":"Mai","year":"2016","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.bulcan.2018.08.003_bib0400","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","article-title":"Lifetime cancer risks in individuals with Germline PTEN mutations","volume":"18","author":"Tan","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.bulcan.2018.08.003_bib0405","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/ng.2224","article-title":"Germline RAD51C mutations confer susceptibility to ovarian cancer","volume":"44","author":"Loveday","year":"2012","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.bulcan.2018.08.003_bib0410","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/ng.893","article-title":"Germline mutations in RAD51D confer susceptibility to ovarian cancer","volume":"43","author":"Breast Cancer Susceptibility Collaboration (UK)","year":"2011","journal-title":"Nat Genet"},{"issue":"22","key":"10.1016\/j.bulcan.2018.08.003_bib0415","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6\u00a0genes in Lynch syndrome","volume":"305","author":"Bonadona","year":"2011","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.bulcan.2018.08.003_bib0420","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/gutjnl-2012-304356","article-title":"Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts","volume":"62","author":"Vasen","year":"2013","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.bulcan.2018.08.003_bib0425","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1086\/421251","article-title":"CHEK2\u00a0breast cancer case-control consortium. CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860\u00a0breast cancer cases and 9,065\u00a0controls from 10\u00a0studies","volume":"74","year":"2004","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.bulcan.2018.08.003_bib0430","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1200\/JCO.2007.12.5922","article-title":"CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000\u00a0patient cases and 27,000\u00a0controls","volume":"26","author":"Weischer","year":"2008","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.bulcan.2018.08.003_bib0435","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv214","article-title":"Germline mutations in the BRIP1, BARD1, PALB2, and NBN genes in women with ovarian cancer","volume":"107","author":"Ramus","year":"2015","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.bulcan.2018.08.003_bib0440","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1158\/1078-0432.CCR-06-0083","article-title":"Frequency and spectrum of cancers in the Peutz-Jeghers syndrome","volume":"12","author":"Hearle","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.bulcan.2018.08.003_bib0445","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/mutage\/get048","article-title":"Functional variants in NBS1\u00a0and cancer risk: evidence from a meta-analysis of 60\u00a0publications with 111\u00a0individual studies","volume":"28","author":"Gao","year":"2013","journal-title":"Mutagenesis"},{"issue":"5","key":"10.1016\/j.bulcan.2018.08.003_bib0450","doi-asserted-by":"crossref","first-page":"e0153788","DOI":"10.1371\/journal.pone.0153788","article-title":"RAD51B in familial breast cancer","volume":"11","author":"Pelttari","year":"2016","journal-title":"PloS One"},{"issue":"26","key":"10.1016\/j.bulcan.2018.08.003_bib0455","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1200\/JCO.2015.61.2408","article-title":"Contribution of Germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian cancer in the population","volume":"33","author":"Song","year":"2015","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.bulcan.2018.08.003_bib0460","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/jnci\/dji141","article-title":"Cancer risks and mortality in heterozygous ATM mutation carriers","volume":"97","author":"Thompson","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bulcan.2018.08.003_bib0470","first-page":"453","article-title":"Hereditary forms of ovarian cancer","volume":"4","author":"Pauw","year":"2012","journal-title":"Bull Cancer (Paris)"},{"key":"10.1016\/j.bulcan.2018.08.003_bib0475","series-title":"GeneReviews\u00ae","article-title":"Lynch syndrome","author":"Kohlmann","year":"1993"},{"issue":"7","key":"10.1016\/j.bulcan.2018.08.003_bib0480","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1053\/j.gastro.2010.02.053","article-title":"One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome","volume":"138","author":"Vasen","year":"2010","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.bulcan.2018.08.003_bib0485","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/jmedgenet-2015-103153","article-title":"Hereditary diffuse gastric cancer syndrome: improved performances of the 2015\u00a0testing criteria for the identification of probands with a CDH1\u00a0germline mutation","volume":"52","author":"Benusiglio","year":"2015","journal-title":"J Med Genet"},{"key":"10.1016\/j.bulcan.2018.08.003_bib0490","series-title":"Chirurgie prophylactique des cancers avec pr\u00e9disposition g\u00e9n\u00e9tique\u00a9","year":"2009"},{"key":"10.1016\/j.bulcan.2018.08.003_bib0495","unstructured":"F. Eisinger, 2015, [https:\/\/www.inserm.fr\/information-en-sante\/dossiers-information\/tests-genetiques]"},{"key":"10.1016\/j.bulcan.2018.08.003_bib0505","unstructured":"R\u00e8gles de bonnes pratiques en g\u00e9n\u00e9tique constitutionnelle \u00e0 des fins m\u00e9dicales. www.has-sante.fr"},{"key":"10.1016\/j.bulcan.2018.08.003_bib0510","series-title":"NCT number NCT03246841","year":"2017"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455118302248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455118302248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T01:21:28Z","timestamp":1539998488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455118302248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0007455118302248"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2018.08.003","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommandations fran\u00e7aises du Groupe G\u00e9n\u00e9tique et Cancer pour l\u2019analyse en panel de g\u00e8nes dans les pr\u00e9dispositions h\u00e9r\u00e9ditaires au cancer du sein ou de l\u2019ovaire","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2018.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}